The present study was aimed to investigate the relationships between dysfunction of cortical glucose metabolism as detectable by means of 2-deoxy-2-[18F]fluoro -D-glucose ([18F]FDG) positron emission tomography/x-ray computed tomography (PET/CT) and amyloid burden as detectable by means of 4-(E)-2-[4-(2-2-[2-[18F]fluoroethoxy]ethoxyethoxy)phenyl]vinyl-N-methylaniline (florbetaben; [18F]FBB) in a group of patients affected by Alzheimer's disease (AD)
International audienceGray matter atrophy, glucose hypometabolism, and β-amyloid Aβ deposition are w...
Current Positron Emission Tomography (PET) biomarkers for Alzheimer’s disease (AD) assess either neu...
This report describes the first human study of a novel amyloid-imaging positron emission tomography ...
The present study was aimed to investigate the relationships between dysfunction of cortical glucose...
none8noPurpose: The present study was aimed to investigate the relationships between dysfunction of ...
Clinical diagnosis of AD remains a challenge since there are no validated tests for an affirmative d...
Aim To investigate the relationships between amyloid burden in brain and the age of onset of Alzheim...
Positron emission tomography (PET) studies using [18F]2-fluoro-2-deoxyglucose (FDG) have identified ...
Purpose The present multimodal neuroimaging study examined whether amyloid pathology and glucose met...
PurposeThe present study was conducted to compare the pattern of brain [F-18] FDG uptake in suspecte...
Both fluorine-18-labeled fluorodeoxyglucose ([18F]FDG) positron emission tomography, examining gluco...
F FDG-PET) has gained a leading role in the diagnostic assessment of patients with cognitive complai...
International audienceGray matter atrophy, glucose hypometabolism, and β-amyloid Aβ deposition are w...
Current Positron Emission Tomography (PET) biomarkers for Alzheimer’s disease (AD) assess either neu...
This report describes the first human study of a novel amyloid-imaging positron emission tomography ...
The present study was aimed to investigate the relationships between dysfunction of cortical glucose...
none8noPurpose: The present study was aimed to investigate the relationships between dysfunction of ...
Clinical diagnosis of AD remains a challenge since there are no validated tests for an affirmative d...
Aim To investigate the relationships between amyloid burden in brain and the age of onset of Alzheim...
Positron emission tomography (PET) studies using [18F]2-fluoro-2-deoxyglucose (FDG) have identified ...
Purpose The present multimodal neuroimaging study examined whether amyloid pathology and glucose met...
PurposeThe present study was conducted to compare the pattern of brain [F-18] FDG uptake in suspecte...
Both fluorine-18-labeled fluorodeoxyglucose ([18F]FDG) positron emission tomography, examining gluco...
F FDG-PET) has gained a leading role in the diagnostic assessment of patients with cognitive complai...
International audienceGray matter atrophy, glucose hypometabolism, and β-amyloid Aβ deposition are w...
Current Positron Emission Tomography (PET) biomarkers for Alzheimer’s disease (AD) assess either neu...
This report describes the first human study of a novel amyloid-imaging positron emission tomography ...